NLE Endocrine & Metabolic Nursing — Adrenal DisordersStudy Notes

The adrenal gland consists of two distinct functional zones: the outer cortex and the inner medulla. This anatomical distinction is crucial because it explains how different hormones are produced and which disorders result from dysfunction in each zone. **Adrenal Cortex (Outer Layer)** produces three major classes of steroid hormones regulated by the hypothalamic-pituitary-adrenal (HPA) axis: - **Glucocorticoids (cortisol):** The primary glucocorticoid, cortisol, is secreted in response to ACTH (adrenocorticotropic hormone) from the anterior pituitary. Cortisol raises blood glucose through gluconeogenesis, suppresses the immune system and inflammation, facilitates the body's response to stress, and regulates fat and protein metabolism. Cortisol secretion follows a diurnal (daily) rhythm—highest in early morning (6–8 AM) and lowest at midnight. This pattern is critical for diagnosis: when it is lost in Cushing's syndrome, cortisol remains elevated throughout the day. - **Mineralocorticoids (aldosterone):** Aldosterone is regulated by the renin-angiotensin-aldosterone system (RAAS) and by serum potassium levels. It retains sodium and water in the kidneys' collecting ducts, thereby increasing blood volume and blood pressure, while promoting potassium excretion. Aldosterone deficiency causes sodium loss, water loss, and hyperkalemia—a dangerous combination. - **Adrenal androgens:** These sex hormones are produced in small quantities under ACTH control. In excess (as in some virilizing tumors), they cause hirsutism and other androgenic effects in women. **Adrenal Medulla (Inner Layer)** produces catecholamines—epinephrine and norepinephrine—released in response to sympathetic nervous system stimulation. These hormones trigger the "fight-or-flight" response: increased heart rate, blood pressure, and glucose mobilization. **The HPA Axis and Negative Feedback:** Cortisol is tightly regulated by a feedback loop. The hypothalamus secretes CRH (corticotropin-releasing hormone), which stimulates the anterior pituitary to release ACTH, which then stimulates the adrenal cortex to release cortisol. High blood cortisol "turns off" further ACTH and CRH release, preventing excess. Understanding this axis is vital because: - It explains why patients on long-term exogenous steroids (e.g., prednisone for asthma or lupus) cannot suddenly stop the medication—the negative feedback has shut down the patient's own ACTH production and adrenal function. - It explains why ACTH levels help differentiate primary adrenal disorders (where ACTH is high as the pituitary tries to stimulate a failing gland) from secondary or tertiary insufficiency (where ACTH is low because the pituitary or hypothalamus is damaged). - It explains hyperpigmentation in primary Addison's: very high ACTH stimulates melanocytes, darkening the skin.

Cushing's syndrome is the **clinical syndrome resulting from chronic exposure to excess glucocorticoid**—either exogenous (e.g., long-term corticosteroid therapy) or endogenous (overproduction by the adrenal glands or ectopic ACTH production). It is one of the most commonly tested adrenal disorders on the NLE because of its prevalence and complex presentation. **Etiology (Causes):** The most common cause globally is **exogenous**—long-term corticosteroid therapy for conditions such as asthma, COPD, systemic lupus erythematosus (SLE), rheumatoid arthritis, or organ transplant rejection. In the Philippines, where access to medical care varies, patients may receive high-dose steroids without adequate education about tapering, increasing the risk of iatrogenic Cushing's. Endogenous causes (10–15% of cases) are classified by ACTH level: - **Cushing's disease (pituitary ACTH-secreting tumor):** Accounts for ~70% of endogenous cases. A microadenoma or macroadenoma in the anterior pituitary produces ACTH, stimulating excess cortisol. Because the tumor's ACTH production is not fully suppressed by the elevated cortisol (feedback is disrupted), both ACTH and cortisol are elevated. - **Adrenal tumor (autonomous cortisol production):** A unilateral adrenal adenoma or carcinoma directly secretes cortisol independent of ACTH. ACTH is low (suppressed by the high cortisol) because the pituitary cannot stimulate an autonomous tumor. - **Ectopic ACTH syndrome:** A non-endocrine tumor (e.g., small-cell lung cancer, carcinoid) produces ACTH, stimulating the adrenal glands. ACTH is very high, and cortisol is markedly elevated. This often presents acutely and severely. **Pathophysiology of Signs & Symptoms:** Every sign of Cushing's syndrome flows from the metabolic and anti-inflammatory effects of excess cortisol: **Metabolic Effects:** - **Hyperglycemia and diabetes:** Cortisol promotes gluconeogenesis (glucose production) and antagonizes insulin, raising fasting and random glucose levels. Patients may develop "steroid-induced diabetes" requiring insulin or oral hypoglycemic agents. - **Central (truncal) obesity with fat redistribution:** Cortisol promotes deposition of fat in the face ("moon face"), the upper back between the shoulders ("buffalo hump" or dorsocervical fat pad), and the abdomen, while causing loss of fat in the extremities (which appear thin and wasted). - **Negative nitrogen balance and muscle wasting:** Excess cortisol is catabolic—it breaks down protein. Muscles atrophy, causing proximal muscle weakness (patients have difficulty rising from a chair or climbing stairs). **Vascular & Electrolyte Effects:** - **Hypertension:** Cortisol has mineralocorticoid activity; it promotes sodium and water retention and increases vascular sensitivity to catecholamines. Blood pressure is elevated in ~80% of Cushing's patients. - **Hypokalemia and metabolic alkalosis:** Sodium retention is paired with potassium loss. Serum potassium may be low, causing muscle weakness, fatigue, and arrhythmia risk. Metabolic alkalosis results from hydrogen ion loss with potassium. **Integumentary (Skin) Manifestations:** - **Purple (violaceous) striae:** These are stretch marks caused by collagen breakdown under high cortisol. Unlike typical stretch marks, they are purple/red and wider (>1 cm), reflecting active collagen degradation. - **Thin, fragile skin:** Loss of collagen and elastic fibers makes skin paper-thin, transparent, and prone to bruising. Even minor trauma (e.g., a blood pressure cuff) causes ecchymosis (bruising). - **Poor wound healing:** Cortisol suppresses inflammation and fibroblast function, delaying wound closure and increasing infection risk post-operatively. **Immunosuppression:** - Cortisol suppresses immune cell activation and reduces inflammatory cytokine production. Patients are susceptible to infections (especially fungal, viral, and opportunistic organisms), but signs may be masked—fever, elevated WBC, and other inflammatory markers may be blunted even during a serious infection. A patient may have pneumonia with only mild cough and no fever. **Skeletal Effects:** - **Osteoporosis and pathologic fractures:** Cortisol inhibits bone formation, promotes bone resorption, and decreases calcium absorption in the GI tract. Patients may develop vertebral compression fractures, hip fractures, or rib fractures with minimal trauma. **Psychiatric & Neurological Effects:** - Mood changes range from depression to anxiety, irritability, and insomnia. Severe cases present with psychosis, paranoia, or suicidal ideation. Cognitive impairment ("steroid dementia") and memory problems can occur. **Reproductive & Sexual Hormonal Effects:** - **In women:** Hirsutism (excess body and facial hair), acne, male-pattern baldness, and amenorrhea or irregular menses result from adrenal androgen excess. - **In men:** Erectile dysfunction and decreased libido. **Hypertension-Related Complications:** - Left ventricular hypertrophy, heart failure, myocardial infarction, and stroke due to sustained high blood pressure.

Diagnosing Cushing's syndrome involves a stepwise approach that first confirms the presence of excess cortisol, then localizes the source (pituitary, adrenal, or ectopic). **Step 1: Confirm Hypercortisolism (Excess Cortisol)** Multiple tests can confirm excess cortisol because the condition is chronic and consistent: - **24-Hour Urinary Free Cortisol (UFC):** The most specific test. Normal is <100 mcg/24 h (or <276 nmol/24 h). In Cushing's, the UFC is consistently elevated because excess cortisol overwhelms the renal threshold and spills into urine. This is considered the gold standard for confirming cortisol excess in most centers. The patient collects all urine for 24 hours (from one morning void to the next morning's first void). Common errors: incomplete collection or contamination, so reinforce the importance of accurate collection. - **Dexamethasone Suppression Tests (DST):** Dexamethasone is a synthetic glucocorticoid that should suppress ACTH and cortisol in healthy people via negative feedback. In Cushing's, this suppression is lost. - **1 mg overnight DST:** The patient takes 1 mg dexamethasone at 11 PM; cortisol is checked the next morning at 8 AM. Normal cortisol is <1.8 mcg/dL. A morning cortisol >1.8 mcg/dL after dexamethasone suggests Cushing's. This is a quick screening test but less specific (false positives occur with depression, obesity, alcoholism, and physical stress). - **2 mg/48-hour Low-Dose DST:** More specific than the 1 mg test. The patient takes 0.5 mg dexamethasone every 6 hours for 48 hours; 24-hour UFC is collected during the second day of dexamethasone. Normal suppression: UFC <25 mcg/24 h. In Cushing's, the UFC remains elevated despite dexamethasone. - **Late-Night (11 PM) Salivary Cortisol:** A non-invasive outpatient test. Cortisol is normally <3 mcg/dL at 11 PM. In Cushing's, the diurnal rhythm is lost and late-night cortisol is elevated. This test is increasingly used because it reflects the loss of diurnal variation, a hallmark of Cushing's. **Step 2: Confirm Loss of Diurnal Rhythm** Cortisol secretion normally peaks at 6–8 AM and reaches its lowest point near midnight. In Cushing's, this rhythm is flat—cortisol remains high throughout the day and night. - **Morning cortisol (8 AM):** elevated. - **Midnight cortisol or 11 PM salivary cortisol:** elevated (should be low). **Step 3: Determine the Source (Differential Diagnosis)** Once hypercortisolism is confirmed, the next step is to localize it—a critical question because management depends on the source. - **ACTH Level:** The key differentiator. - **ACTH elevated (>10 pg/mL):** The pituitary or another tissue is producing ACTH, driving the adrenal glands to produce excess cortisol. This rules out primary adrenal disease (adrenalectomy for diagnosis is wrong here; the problem is ACTH production, not the adrenals). - **ACTH low or undetectable (<5 pg/mL):** The adrenal gland itself is producing excess cortisol independent of ACTH. This points to adrenal tumor. - **High-Dose Dexamethasone Suppression Test (HDST):** Used to differentiate pituitary-dependent Cushing's disease from ectopic ACTH. - The patient takes 2 mg dexamethasone every 6 hours for 48 hours (fourfold higher dose than low-dose); 24-hour UFC or plasma cortisol is measured during the second day. - **In Cushing's disease (pituitary adenoma):** The pituitary tumor is more sensitive to suppression than other tissues. Higher-dose dexamethasone suppresses the tumor's ACTH secretion, and cortisol falls (UFC drops >50% from baseline). - **In ectopic ACTH (lung cancer, carcinoid):** The tumor is insensitive to dexamethasone. Cortisol does not suppress; UFC remains elevated despite high-dose dexamethasone. - **In adrenal tumor:** ACTH is already low; dexamethasone does not further suppress it (ACTH is already suppressed by the high cortisol). Cortisol does not suppress because the adrenal tumor is autonomous. - **Corticotropin-Releasing Hormone (CRH) Stimulation Test:** Can help differentiate pituitary from ectopic ACTH. In pituitary disease, CRH stimulates the tumor to produce more ACTH and cortisol. In ectopic ACTH, the tumor does not respond to CRH. This test is less commonly used now but may appear on the NLE. **Step 4: Imaging to Localize the Tumor** - **If ACTH is high and HDST shows suppression (pituitary disease):** **MRI pituitary** with contrast to visualize a microadenoma or macroadenoma. - **If ACTH is high and HDST shows no suppression (ectopic ACTH):** **CT chest/abdomen** (to find a lung or abdominal tumor producing ACTH) and **somatostatin receptor scintigraphy (octreoscan)** if needed. - **If ACTH is low (adrenal tumor):** **CT or MRI adrenal** to identify a nodule or mass. **Clinical Pearl for the NLE:** The combination of **high 24-hour UFC + loss of diurnal rhythm + specific ACTH level pattern** tells you the diagnosis without always needing all tests. For example: - **High UFC + low ACTH = adrenal tumor** (do not do HDST; proceed to adrenal imaging and surgical planning). - **High UFC + high ACTH + suppression on HDST = Cushing's disease** (pituitary surgery is the definitive treatment). - **High UFC + very high ACTH + no suppression on HDST + lung findings = ectopic ACTH** (treat the underlying malignancy).

Nursing management of Cushing's syndrome focuses on treating the underlying cause (stopping exogenous steroids, surgical removal of a tumor, or chemotherapy for ectopic ACTH), managing the metabolic and cardiovascular consequences, protecting the patient from injury and infection, and preparing for the transition to adrenal insufficiency post-operatively. **Addressing the Primary Cause:** **Exogenous Cushing's (Most Common):** - **NEVER stop steroids abruptly.** The most critical patient teaching point. Long-term exogenous steroids suppress ACTH and cause adrenal atrophy; abrupt cessation leaves the patient unable to mount a cortisol response to stress, resulting in adrenal crisis (hypotension, shock, hyperkalemia, hyponatremia, hypoglycemia). - **Gradual taper** is essential. The rate of taper depends on the dose and duration of steroid therapy. A patient on prednisone 10 mg daily for 6 months might taper by 2.5 mg every 1–2 weeks, while a patient on 50 mg daily for 2 years requires a slower taper (e.g., 5 mg every 1–2 weeks). The adrenal glands recover over weeks to months; ACTH and cortisol levels should normalize as the dose decreases. - **Stress dosing during taper:** If the patient experiences acute stress (surgery, infection, illness), increase the steroid dose temporarily to prevent adrenal crisis. For example, a patient undergoing a dental procedure might increase the dose by 25%; a patient with pneumonia might double the dose. - **Educate the patient:** Explain why steroids cannot be stopped abruptly and the signs of adrenal insufficiency (weakness, dizziness, nausea, abdominal pain) to report immediately. Provide written taper schedules; many Filipino patients have limited health literacy and need clear, step-by-step instructions. **Surgical Treatment (Pituitary or Adrenal Tumor):** - **For Cushing's disease (pituitary adenoma):** Transsphenoidal pituitary surgery is the gold standard. The tumor is removed via the nose and sphenoid sinus without opening the cranium, reducing morbidity. After surgery, the patient loses the source of excess ACTH, and cortisol production normalizes. - **For adrenal tumor:** Adrenalectomy (unilateral or bilateral, depending on whether both glands are affected) is the definitive treatment. However, surgical removal of the tumor-bearing adrenal gland eliminates that gland's cortisol production. If unilateral, the remaining gland may be suppressed initially (from negative feedback during the high-cortisol state) but typically recovers over weeks to months. If bilateral adrenalectomy is necessary, the patient loses all cortisol-producing tissue and requires **lifelong steroid replacement.** **Pre-operative Nursing Care (Pituitary/Adrenal Surgery):** 1. **Baseline Assessment:** - Document blood pressure (may be very high), weight, and blood glucose. - Assess for osteoporosis risk; determine if the patient has had fractures or significant bone loss on DEXA scan. - Assess skin integrity—fragile skin is at high risk for breakdown during surgery and post-operative care. - Screen for mood disturbances; post-operative depression is common and requires support. 2. **Metabolic Optimization:** - **Blood pressure control:** If hypertensive, initiate antihypertensive therapy. However, post-operatively, blood pressure may drop dramatically as cortisol falls, so avoid over-aggressive blood pressure management pre-op. - **Glucose management:** If hyperglycemic, optimize glucose control to improve wound healing, but be aware that post-operatively, as cortisol falls, insulin requirements will decrease. - **Electrolyte correction:** Ensure potassium is repleted if hypokalemic (K+ should be >3.5 mEq/L pre-operatively). - **Protein and nutrition:** Encourage high-protein diet to support wound healing (cortisol is catabolic and has impaired healing). 3. **Steroid Coverage for Surgery:** - **Crucial point:** Because the adrenal glands are highly vascular and adjacent to major vessels, surgery is a major physiologic stress. Patients require **large peri-operative doses of IV corticosteroids** to prevent adrenal crisis from the acute loss of cortisol production and the stress of surgery. - **Typical regimen:** Hydrocortisone (a fast-acting glucocorticoid) 50–100 mg IV immediately before surgery, then 50 mg IV every 6–8 hours during and immediately after surgery (first 24–48 hours). The dose is then tapered over several days as the patient recovers and oral intake resumes. - **Post-operative taper:** The hydrocortisone is gradually reduced as the patient stabilizes. If the remaining adrenal tissue recovers (unilateral adrenalectomy), the patient is eventually weaned off steroids. If bilateral adrenalectomy, lifelong replacement with hydrocortisone and fludrocortisone is necessary. **Post-operative Nursing Priorities:** 1. **Monitor for Hemorrhage and Shock:** - The adrenal glands are retroperitoneal and highly vascular. Bleeding can be catastrophic. - **Check vital signs every 15 minutes for the first 2 hours, then every 30 minutes for the next 2 hours, then hourly.** - **Inspect the surgical dressing frequently.** If blood soaks through and saturates the dressing, notify the surgeon immediately. - **Assess for signs of hemorrhage:** tachycardia, hypotension, pale/cool skin, restlessness, decreased urine output, and rising abdominal distention. - **Monitor Hemoglobin and Hematocrit** serially; a significant drop suggests ongoing bleeding. 2. **Manage the Acute Loss of Cortisol (Adrenal Insufficiency):** - Post-operatively, as cortisol production plummets (or is surgically removed), the patient is at risk for hypotension, shock, and adrenal crisis if the peri-operative hydrocortisone dose is inadequate. - **Monitor blood pressure closely.** Expect a drop post-operatively; this is normal as excess cortisol is removed. However, **hypotension (systolic <90 mmHg) or symptomatic hypotension (dizziness, weakness, confusion) requires immediate IV fluids and possibly increased hydrocortisone.** - **IV fluids:** Initiate normal saline (0.9% NaCl) to expand intravascular volume and support blood pressure. The patient is now deficient in aldosterone (if bilateral adrenalectomy) and cannot retain sodium, making normal saline especially important. - **Monitor and correct electrolytes:** Watch for hyponatremia and hyperkalemia (if both adrenals are removed); these may develop rapidly if steroid replacement is inadequate. 3. **Monitor Glucose and Metabolic Changes:** - As cortisol levels fall post-operatively, **hypoglycemia risk increases.** Patients who were hyperglycemic pre-operatively may no longer need insulin post-operatively. - **Check blood glucose every 2–4 hours post-operatively.** If hypoglycemic (glucose <70 mg/dL), give dextrose IV or oral carbohydrate. - Educate the patient: once home, cortisol is no longer elevated, so diet changes may be needed. Weight loss is expected as fat redistribution reverses. 4. **Pain Management:** - Use multimodal analgesia (opioids + NSAIDs + acetaminophen). Pain is a physiologic stress that increases cortisol demand; adequate pain control is essential. - Remember that the patient's pain perception and inflammatory responses may have been blunted by high cortisol; pain may seem less severe than the injury warrants, potentially delaying recognition of complications. 5. **Infection Prevention and Monitoring:** - The patient has been immunosuppressed by high cortisol and is now at risk for post-operative infection. - **Give prophylactic antibiotics as ordered; continue for the first post-operative day.** - **Monitor the surgical wound and dressing for signs of infection:** increasing redness, warmth, purulent drainage, or separation. - **Monitor temperature regularly.** The patient may not develop a high fever even with serious infection (immunosuppression masks inflammation), so remain vigilant even if temperature is only mildly elevated. - Encourage early mobilization and deep breathing to prevent respiratory infection (pneumonia). 6. **Skin Care and Wound Healing:** - The patient's skin is fragile and healing is impaired; handle gently. - **Inspect skin frequently for breakdown,** especially over pressure points (sacrum, heels, elbows). Use pressure-relief devices (foam mattress, pillows). - **Avoid tape and adhesives when possible.** If needed, use gentle removal and apply skin protectant. - **Support wound healing:** ensure adequate protein intake, vitamin C supplementation, and zinc if deficient. 7. **Bone Health Considerations:** - If the patient has osteoporosis, handle carefully during transfers and positioning to prevent pathologic fractures. - Assist with early mobilization to prevent further bone loss. - Plan post-operative bone protection: calcium and vitamin D supplementation, weight-bearing exercises as tolerated, and possibly bisphosphonates. 8. **Psychological Support:** - Post-operative depression and mood changes are common as cortisol and stress hormone levels normalize. The patient may feel fatigued and emotionally fragile. - Provide emotional support; reassure the patient that mood will stabilize as hormones normalize. - Screen for depression; refer to a mental health professional if needed. - Prepare for positive physical changes: weight normalization, resolution of purple striae, and normalization of skin fragility—these take time and provide motivation. **Post-Operative Discharge Teaching:** - **Steroid replacement (if applicable):** If the patient is on lifelong steroid replacement (bilateral adrenalectomy), teach the importance of never stopping steroids, stress dosing, and medical alert identification. - **Monitoring:** Have the patient follow up with endocrinology in 1–2 weeks and again at 3 months. Cortisol and ACTH levels should normalize; if not, recurrence of disease is possible (pituitary tumor recurrence in ~10% of Cushing's disease cases). - **Activity:** Avoid heavy lifting for 6 weeks; return to normal activity as tolerated. - **Follow-up:** Regular blood pressure, weight, and glucose monitoring; annual DEXA scan if osteoporosis is present.

Addison's disease (primary adrenal insufficiency) is the **clinical syndrome resulting from deficient production of cortisol and aldosterone** by the adrenal cortex. It is the mirror-image diagnosis to Cushing's syndrome—where Cushing's is "too much," Addison's is "too little." Understanding the contrast is crucial for NLE success because the manifestations, diagnostics, and emergency management are opposite. **Etiology (Causes):** **Primary Addison's Disease (Cortex Destruction):** - **Autoimmune adrenalitis (60–70% in developed countries):** Antibodies attack the adrenal cortex, gradually destroying it. This is the most common cause in the United States and Europe. Autoimmune Addison's is often associated with other autoimmune endocrine disorders (autoimmune thyroiditis, type 1 diabetes, hypogonadism, pernicious anemia), forming autoimmune polyglandular syndrome (APS). In the Philippines, where infectious disease prevalence is higher, tuberculosis remains a significant cause. - **Tuberculosis (TB) (20–30% globally; higher in the Philippines and other endemic areas):** Mycobacterium tuberculosis spreads hematogenously to the adrenal glands, causing caseous necrosis and fibrosis, gradually destroying both cortices. This is a critical clinical pearl for Filipino nurses: **suspect Addison's in any patient with TB and unexplained hypotension, hyponatremia, or hyperkalemia.** TB-related Addison's often develops over months as the infection smolders, and it can present acutely if stress (concurrent infection, surgery) occurs in a patient with chronic TB adrenalitis. - **Adrenoleukodystrophy (ALD):** A rare X-linked metabolic disorder causing accumulation of very-long-chain fatty acids in the adrenal cortex and nervous system. Presents in childhood with progressive adrenal insufficiency and neurological decline. - **Bilateral adrenalectomy:** Surgical removal of both adrenal glands (for treatment of severe Cushing's syndrome or adrenal cancer) eliminates all cortisol and aldosterone production, causing acute Addison's. - **Medications:** Mitotane (used to treat adrenocortical carcinoma), ketoconazole (antifungal), and metyrapone (11β-hydroxylase inhibitor used to treat Cushing's) inhibit cortisol synthesis. - **Infiltrative diseases:** Metastatic cancer to the adrenal glands, lymphoma, sarcoidosis, and amyloidosis can destroy the cortex. - **Other infections:** Fungal infections (histoplasmosis, coccidioidomycosis—relevant in specific geographic areas), HIV/AIDS with opportunistic infections (CMV, tuberculosis). **Secondary Adrenal Insufficiency (Pituitary ACTH Deficiency):** - **Abrupt steroid withdrawal:** The most common cause of secondary insufficiency. Exogenous steroids suppress ACTH and cause the adrenal cortex to atrophy. If steroids are stopped abruptly or tapered too quickly, the cortex cannot immediately respond, and the patient develops acute adrenal insufficiency. - **Pituitary disease:** Tumor, infarction (Sheehan's syndrome post-partum hemorrhage, pituitary apoplexy), surgery, radiation, or autoimmune hypophysitis damages the pituitary and reduces ACTH secretion. - **Hypothalamic disease:** Tumors, surgery, or trauma damage the hypothalamus and reduce CRH secretion, leading to secondary insufficiency. **Tertiary Adrenal Insufficiency (Hypothalamic CRH Deficiency):** - Less common; results from hypothalamic disease or chronic exogenous steroid use (which suppresses endogenous CRH and ACTH). **Pathophysiology of Signs & Symptoms:** The symptoms of Addison's disease stem from deficiency of both cortisol (which affects glucose metabolism, stress response, and cardiovascular stability) and aldosterone (which regulates sodium, potassium, and water). **Hypotension and Cardiovascular Effects:** - **HYPOTENSION** is the most critical consequence: Aldosterone deficiency → sodium loss → water loss → hypovolemia (low blood volume). Cortisol deficiency → loss of vascular tone and catecholamine sensitivity. Together, these cause profound hypotension (systolic often <90 mmHg, sometimes <70 mmHg). - **Orthostatic hypotension:** Dizziness upon standing; patients may faint. - **Tachycardia:** The body attempts to compensate for low blood pressure by increasing heart rate. - **Shock:** In severe/acute cases (adrenal crisis), hypotension progresses to cardiogenic shock—peripheral vasoconstriction, cold extremities, and altered mental status. **Electrolyte Abnormalities:** - **HYPONATREMIA (low sodium, <130 mEq/L):** Aldosterone loss → sodium wasting in kidneys → low serum sodium. Symptoms include weakness, confusion, headache, seizures (if severe and acute). Hyponatremia also worsens hypotension by reducing serum osmolality. - **HYPERKALEMIA (high potassium, >5.5 mEq/L):** Aldosterone loss → impaired renal potassium excretion → high serum potassium. Hyperkalemia is life-threatening because it causes cardiac arrhythmias (peaked T waves, prolonged QRS, bradycardia, eventual cardiac standstill). The patient may feel muscle weakness or palpitations. **Hypoglycemia and Metabolic Effects:** - **HYPOGLYCEMIA:** Cortisol normally promotes gluconeogenesis (glucose production from amino acids and lactate). Without cortisol, fasting glucose falls, especially during stress or after a period without food. Patients experience shakiness, anxiety, sweating, and altered mental status. - **Fasting hypoglycemia** may be subtle (glucose 60–70 mg/dL) in mild Addison's or severe (glucose <50 mg/dL) in acute crisis. - **Weight loss, anorexia, nausea, vomiting, diarrhea:** Without cortisol's permissive effects on GI motility and appetite, patients lose weight and have GI symptoms. Diarrhea contributes to electrolyte loss. **Fatigue and Weakness:** - **Profound fatigue, lethargy, and apathy:** Cortisol deficiency impairs the stress response; patients feel exhausted even with minimal exertion. - **Muscle weakness:** Sodium and potassium derangements impair muscle function. - **Inability to perform ADLs:** Patients may struggle to work, care for themselves, or engage socially. **Hyperpigmentation (in Primary Addison's Only):** - **Bronze or tan skin, especially in sun-exposed areas and over friction points (lips, nipples, scars, creases).** This is pathognomonic (highly characteristic) of primary Addison's and reflects **very high ACTH levels**. In primary Addison's, the failing adrenal cortex cannot suppress ACTH via negative feedback, so ACTH rises dramatically (often >100 pg/mL). High ACTH stimulates melanocytes via the melanocyte-stimulating hormone (MSH) peptide generated from ACTH's parent molecule, increasing melanin production and darkening the skin. - **Hyperpigmentation is absent in secondary/tertiary insufficiency** (where ACTH is low or normal), making it a clinical clue to the type of insufficiency. **Salt Craving:** - **Intense desire for salty foods:** Aldosterone deficiency → sodium loss → the body senses low sodium and creates a drive to consume salt. This is a common and often overlooked symptom. **Psychiatric and Neurological Effects:** - **Personality changes, depression, anxiety, irritability, and apathy:** The stress response is compromised, and cortisol affects mood and cognition. - **Altered mental status in acute crisis:** Confusion, disorientation, and lethargy from hypoglycemia, hyponatremia, and hypotension. **Chronic Manifestations vs. Acute Crisis:** - **Chronic (insidious onset over weeks to months):** Fatigue, weight loss, orthostatic dizziness, salt craving, mild hyponatremia (130–135 mEq/L), hyperkalemia (5.5–6.5 mEq/L), and mild hypoglycemia (70–90 mg/dL). The patient adapts, though quality of life is poor. - **Acute adrenal crisis:** Triggered by stress (infection, surgery, trauma, dehydration), acute exacerbation presents with acute hypotension (systolic <90 mmHg or a sudden drop >30 mmHg from baseline), severe hyponatremia (<120 mEq/L), severe hyperkalemia (>7 mEq/L with EKG changes), severe hypoglycemia (<50 mg/dL), high fever, severe vomiting/diarrhea/dehydration, and shock. This is a medical emergency.

Diagnosing Addison's disease requires demonstrating cortisol deficiency and then determining whether it is primary (high ACTH) or secondary/tertiary (low ACTH). **Step 1: Confirm Adrenal Insufficiency (Low Cortisol)** - **Morning Cortisol (8 AM):** The single most practical test. Normal morning cortisol is >10–15 mcg/dL (varies by lab). A cortisol <3 mcg/dL at 8 AM is diagnostic of adrenal insufficiency; a cortisol of 3–10 mcg/dL is suspicious and warrants further testing. - **ACTH Stimulation Test (Cosyntropin Test):** The gold standard test for confirming adrenal insufficiency and differentiating primary from secondary. - **Protocol:** The patient receives an IV injection of cosyntropin (synthetic ACTH), 250 mcg IV or IM. Cortisol is measured at baseline and at 30 and 60 minutes. - **Normal response:** Cortisol rises to >18–20 mcg/dL within 30 minutes (the adrenal cortex is functional and responds to ACTH). - **Primary Addison's:** Cortisol **fails to rise** after cosyntropin because the adrenal cortex is destroyed and cannot produce cortisol despite being stimulated. Baseline and stimulated cortisol remain low (<5 mcg/dL). - **Secondary/Tertiary Addison's:** Cortisol **rises** after cosyntropin to >18 mcg/dL because the adrenal cortex is still intact and capable of responding; the problem is lack of ACTH (from pituitary/hypothalamic disease). This test differentiates secondary insufficiency (adrenal gland is functional but understimulated) from primary insufficiency (adrenal gland is destroyed). **Step 2: Measure ACTH and Determine the Level of Insufficiency** - **ACTH Level:** - **High (>100 pg/mL):** Primary Addison's. The failing adrenal cortex cannot suppress ACTH via negative feedback, so ACTH rises dramatically trying to stimulate the damaged gland. - **Low or normal (<10 pg/mL):** Secondary or tertiary insufficiency. The pituitary (secondary) or hypothalamus (tertiary) is not producing enough ACTH/CRH. - **Intermediate (10–50 pg/mL):** Can occur in early primary insufficiency or in secondary insufficiency; further testing (cosyntropin test) helps clarify. **Step 3: Measure Electrolytes and Glucose** - **Sodium:** Hyponatremia (<130 mEq/L) suggests primary insufficiency (aldosterone loss); it can also occur in secondary insufficiency but is usually milder because some aldosterone is often retained. - **Potassium:** Hyperkalemia (>5.5 mEq/L) is characteristic of primary insufficiency (aldosterone loss); it is absent or mild in secondary insufficiency. - **Glucose:** Hypoglycemia (fasting glucose <70 mg/dL) suggests cortisol deficiency. - **The electrolyte pattern is often diagnostic:** Hyponatremia + hyperkalemia + low cortisol + high ACTH = primary Addison's. Hyponatremia + low-normal potassium + low cortisol + low ACTH = secondary insufficiency. **Step 4: Identify the Cause (Primary vs. Secondary, and the Specific Etiology)** **For Primary Addison's:** - **Adrenal autoantibodies (21-hydroxylase antibodies, 17α-hydroxylase antibodies):** Present in ~50% of autoimmune Addison's. If positive, confirms autoimmune adrenalitis. - **TB risk assessment and imaging:** If TB is suspected (patient has TB history, endemic area, abnormal chest X-ray, or adrenal calcification on CT), perform chest X-ray and abdominal CT. TB adrenalitis often causes "adrenal calcification" (a rim of calcium deposition) visible on CT. - **Imaging (CT or MRI adrenal):** If adrenal autoantibodies are negative or TB is suspected, image the adrenal glands to assess size (in autoimmune Addison's, glands may be small; in TB, they may be enlarged with calcification; in advanced HIV/AIDS with opportunistic infections, glands may be enlarged or destroyed). - **Other screening:** Check thyroid function (TSH, free T4) to assess for autoimmune thyroiditis (common in autoimmune polyglandular syndrome); screen for type 1 diabetes (fasting glucose, HbA1c); consider other autoimmune diseases if the clinical picture suggests it. **For Secondary Addison's:** - **MRI pituitary and hypothalamus:** To identify pituitary tumor, infarction, or hypothalamic disease. - **Prolactin, TSH, growth hormone levels:** To assess other pituitary hormone deficiencies (panhypopituitarism). - **History:** Carefully review steroid use, pituitary/head surgery, pituitary radiation, or history of pituitary disease. **Clinical Pearl for the NLE:** The combination of **low morning cortisol + high ACTH + hyponatremia + hyperkalemia** is virtually diagnostic of primary Addison's without requiring a cosyntropin test. The electrolyte pattern alone often gives away the diagnosis. Conversely, **low cortisol + low ACTH + hypotension after recent steroid withdrawal** indicates secondary insufficiency from abrupt steroid cessation.

An **adrenal crisis is an acute, life-threatening deficiency of cortisol** precipitated by acute stress in a patient with underlying adrenal insufficiency (diagnosed or unrecognized). It is a medical emergency requiring immediate recognition and treatment. The NLE tests this extensively because the management is straightforward but critical: IV hydrocortisone and IV fluids can be lifesaving. **Triggers (Precipitating Factors):** Any physiologic stress can trigger a crisis in a patient whose adrenal glands are damaged or suppressed: - **Acute infection:** Pneumonia, urinary tract infection, meningitis, sepsis, gastroenteritis, or any acute bacterial/viral illness. - **Trauma or surgery:** Major surgical procedures (especially adrenalectomy or pituitary surgery, where cortisol production is acutely lost), severe burns, or motor vehicle accidents. - **Acute medical illness:** Myocardial infarction, pulmonary embolism, diabetic ketoacidosis, or acute stroke. - **Medications:** Abrupt steroid withdrawal (most common cause of secondary adrenal crisis), initiation of mitotane or ketoconazole in a patient with baseline adrenal insufficiency. - **Dehydration or excessive heat:** Loss of fluid/electrolytes without steroid supplementation. - **Pregnancy and labor:** Especially the third trimester and labor (both increased metabolic demands and stress). - **Emotional or psychological stress:** Rarely alone, but combined with another stressor (e.g., stress + infection). **Clinical Presentation of Adrenal Crisis:** Signs develop acutely or subacutely (over hours to 1–2 days) and reflect the triad of **severe hypotension + severe electrolyte abnormalities + severe hypoglycemia**: **Cardiovascular Collapse:** - **SEVERE HYPOTENSION:** Systolic <90 mmHg or a sudden drop >30 mmHg from the patient's baseline (patients with chronic Addison's may have baseline systolic 90–100; an acute drop is alarming). This reflects acute loss of intravascular volume (aldosterone-deficient kidneys cannot retain sodium/water) + loss of vascular tone (cortisol deficiency) + direct catecholamine insufficiency. - **TACHYCARDIA:** Compensatory; heart rate often >100 bpm. - **Shock:** Peripheral vasoconstriction, cold clammy skin, poor perfusion, altered mental status, decreased urine output (oliguria), and progression to cardiogenic shock if untreated. - **Syncope:** Patients may collapse and lose consciousness from hypotension. **Electrolyte Derangements:** - **SEVERE HYPONATREMIA (<120 mEq/L):** Sodium wasting via aldosterone-deficient kidneys. The low sodium worsens shock by reducing osmolality, drawing fluid into cells. Acute hyponatremia (<24–48 hours) causes cerebral edema with headache, altered mental status, seizures, and coma. - **SEVERE HYPERKALEMIA (>7 mEq/L with EKG changes):** Impaired renal potassium excretion (no aldosterone). Hyperkalemia causes **peaked T waves, widened QRS complex, ST depression, bradycardia, and in severe cases, ventricular fibrillation or cardiac standstill.** This is immediately life-threatening. **Metabolic Derangements:** - **SEVERE HYPOGLYCEMIA (<50 mg/dL, often <40 mg/dL):** Cortisol deficiency → loss of gluconeogenesis + stress consumes glucose. Severe hypoglycemia causes altered mental status, seizures, and loss of consciousness. Hypoglycemia also worsens shock by impairing cardiac function. **Gastrointestinal Symptoms:** - **Severe nausea, vomiting, and diarrhea:** Exacerbate fluid and electrolyte loss. - **Abdominal pain:** Often severe; may mimic acute abdomen (appendicitis, perforation) in some presentations. **Fever and Infection Signs:** - **High fever (38.5–40°C or higher):** If crisis is triggered by infection. However, the immunosuppression may blunt the fever response, and some patients have only mild fever despite serious infection. - **Signs of sepsis:** If bacteremia is present (hypotension, tachycardia, altered mental status). **Neurological and Psychiatric Changes:** - **Altered mental status:** Confusion, disorientation, delirium, lethargy, or coma (from hypoglycemia, hyponatremia, hypotension, and CNS hypoperfusion). - **Severe weakness and malaise.** - **Irritability, agitation, or psychosis** (rare but can occur). **Distinguishing Features by Cause:** - **Primary adrenal crisis:** Hyponatremia + hyperkalemia + hypoglycemia (classic triad); hyperpigmentation may be visible (bronze skin). - **Secondary adrenal crisis (from steroid withdrawal):** Hypotension + hypoglycemia (hyponatremia and hyperkalemia are usually mild or absent because aldosterone is often preserved if only the pituitary is affected); no hyperpigmentation. **Critical Diagnostic Clue:** In any patient presenting with **unexplained hypotension + hyponatremia + hyperkalemia + hypoglycemia,** especially if the patient has a history of adrenal insufficiency, TB, autoimmune disease, or recent steroid withdrawal, **suspect adrenal crisis immediately.** Do not delay treatment to await test confirmation; hydrocortisone is both diagnostic and therapeutic. **Immediate Management (Priority Order):** **1. IV Hydrocortisone (Glucocorticoid) — THE PRIORITY** - **Dose:** 50–100 mg IV bolus immediately, then 50–100 mg IV every 6–8 hours for the first 24 hours. Some protocols call for continuous infusion: 100 mg in the first hour, then 50–100 mg every 2–4 hours. - **Rationale:** Hydrocortisone (not prednisone or dexamethasone) because it is faster-acting and has mild mineralocorticoid activity (aldosterone action), which is needed to retain sodium and raise blood pressure. - **Effect:** Within 10–15 minutes, blood pressure begins to rise, shock improves, and glucose is mobilized. Continuation prevents further deterioration. **2. IV Fluids — Critical for Hypovolemia** - **Type and composition:** **Normal saline (0.9% NaCl) with 5% dextrose** (or 5% dextrose in normal saline, D5NS). - **Rationale:** Normal saline replaces the sodium and water lost via the aldosterone-deficient kidneys. Dextrose corrects hypoglycemia and provides immediate calories. Do not use hypotonic fluids (0.45% saline or 5% dextrose in water); they worsen hyponatremia by diluting the remaining sodium. - **Rate:** Aggressive; typically 1 L normal saline over 1 hour if shock is severe, then continue at 500 mL per hour until blood pressure stabilizes. Titrate to urine output (goal 0.5–1 mL/kg/h) and blood pressure improvement. - **Monitoring:** Check sodium and glucose every 2–4 hours initially. As fluids are given and hydrocortisone takes effect, sodium should gradually rise (target correction is slow—no more than 10 mEq/L in 24 hours—to avoid osmotic demyelination syndrome if hyponatremia is severe and chronic). **3. Treat Hyperkalemia (if K+ >7 mEq/L or EKG changes present)** - **EKG monitoring:** Continuous monitoring to detect peaked T waves, widened QRS, or bradycardia (signs of dangerous hyperkalemia). - **Calcium gluconate:** 10 mL of 10% calcium gluconate IV over 2–3 minutes (stabilizes cardiac membrane, reduces hyperkalemia risk of arrhythmia; does NOT lower potassium but buys time). Repeat every 5–10 minutes if EKG changes persist. - **Insulin with dextrose:** 10 units regular insulin IV, given with 25 g dextrose (e.g., 50 mL of 50% dextrose or 1 L of 5% dextrose) to shift potassium intracellularly. Effect in 10–15 minutes; lasts 4–6 hours. - **Sodium bicarbonate:** 50 mEq (one amp) IV over 5 minutes if acidemia is present (common in crisis); shifts potassium intracellularly. - **Diuretics (furosemide):** 40–80 mg IV if volume overload develops (less common in acute crisis but important if fluids are aggressively given). Promotes renal potassium excretion, but patient must be euvolemic. - **Potassium binders (sodium polystyrene sulfonate, patiromer, sodium zirconium cyclosilicate):** Give orally or rectally to bind potassium in the gut; less effective acutely but continued for hours to days if hyperkalemia persists. - **Goal:** K+ 5.5–6.0 mEq/L within 2–4 hours; normal by 24 hours as aldosterone effect increases from hydrocortisone administration. **4. Identify and Treat the Precipitating Cause** - **Culture blood and urine; get chest X-ray, ECG, and abdominal imaging as indicated** to identify infection, MI, or other acute illness. - **Start broad-spectrum antibiotics** (after cultures) if infection is suspected (e.g., ceftriaxone + vancomycin if meningitis suspected; fluoroquinolone for urinary symptoms). - **Manage the underlying condition:** If sepsis is present, follow sepsis protocols; if MI is suspected, EKG and troponins guide care. **5. Monitoring and Reassessment** - **Vital signs:** Every 15 minutes for the first 1–2 hours, then every 30 minutes for the next 2 hours, then hourly as patient stabilizes. Goal: systolic BP >90 mmHg and heart rate 80–110 bpm. - **Lab draws:** Electrolytes (Na, K), glucose, Mg, Ca, BUN/creatinine, and complete blood count at baseline, 2 hours, and 4 hours, then every 4–6 hours until stable. Arterial blood gas if shock is severe. - **Urine output:** Goal 0.5–1 mL/kg/h; oliguria (<0.5 mL/kg/h) suggests ongoing shock. - **Cortisol and ACTH levels:** Draw at baseline before giving hydrocortisone (if possible) to support the diagnosis; exogenous hydrocortisone will elevate cortisol, but ACTH can still be measured and may aid future diagnosis. **Post-Crisis Recovery Phase:** - **Hydrocortisone taper:** After the first 24–48 hours, once blood pressure is stable and the patient is tolerating oral intake, gradually reduce IV hydrocortisone. - **Day 2:** 50 mg IV every 8 hours (150 mg total). - **Day 3:** 25 mg IV every 6 hours, or transition to oral: 20 mg morning, 10 mg afternoon, 10 mg evening. - **By day 5–7:** Reach maintenance dose (typically 15–25 mg daily in divided doses for hydrocortisone, plus 0.05–0.1 mg daily of fludrocortisone). - **Fluid management:** As blood pressure stabilizes, reduce IV fluid rate but maintain sodium correction slowly (no faster than 10 mEq/L per 24 hours if hyponatremia is chronic). - **Identify the underlying adrenal insufficiency:** If the patient was previously undiagnosed, now is the time for formal testing (ACTH stimulation) and long-term management planning. - **Education:** Discharge teaching on steroid adherence, sick-day rules, medical alert identification, emergency hydrocortisone kit (IM hydrocortisone for self-injection), and follow-up with endocrinology. **Prevention of Recurrent Crises (Discharge Teaching):** - **Never stop steroids abruptly.** - **Increase steroid dose during illness/stress (sick-day rules):** Fever, infection, surgery, or major stress requires doubling or tripling the normal dose during the acute period, then returning to baseline as the stressor resolves. - **Medical alert identification:** Wear a medical alert bracelet or necklace stating "Adrenal insufficiency" and listing the patient's steroid doses. - **Emergency hydrocortisone kit:** Provide a prescription for IM hydrocortisone (e.g., Solu-Cortef 100 mg in a pre-filled syringe or vial). Teach the patient and a family member how to inject it IM if the patient becomes unconscious or unable to swallow (severe vomiting, shock). - **Routine follow-up:** Endocrinology visit within 1–2 weeks; annual or biannual visits thereafter.

A **pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla** (or rarely, extra-adrenal chromaffin tissue—"paraganglioma"). It is a rare but critical diagnosis because it causes severe, often episodic hypertension and can precipitate life-threatening hypertensive crises or sudden cardiac death. The classic presentation and diagnostic approach are frequently tested on the NLE. **Pathophysiology:** The adrenal medulla normally secretes epinephrine in response to sympathetic nervous system stimulation. A pheochromocytoma is usually a benign adenoma (90%) but can be malignant (10%) and produces excessive catecholamines—epinephrine and norepinephrine—either continuously or in episodic "attacks." The tumor is not under normal neural control, so release of catecholamines is autonomous and unpredictable. The massive catecholamine surge causes a paroxysmal (episodic) or sustained hypertensive crisis with end-organ damage (heart, brain, kidneys). **Epidemiology & Risk Factors:** - **Incidence:** ~0.1% of hypertensive patients; rare (<1 per 10,000 population). - **Age of onset:** Typically 40–50 years; can present in childhood if familial. - **Hereditary syndromes** (10–15% of pheochromocytomas are familial): - **Multiple endocrine neoplasia type 2A and 2B (MEN2A/MEN2B):** Medullary thyroid carcinoma + pheochromocytoma (+ parathyroid adenoma in MEN2A). - **Von Hippel-Lindau syndrome (VHL):** Hemangioblastomas + pheochromocytoma + renal cysts/cancer + pancreatic cysts. - **Neurofibromatosis type 1 (NF1):** Neurofibromas + optic nerve gliomas + pheochromocytoma. - **Familial paraganglioma syndromes (SDH mutations):** Extra-adrenal catecholamine-secreting tumors. **Clinical Presentation:** **The Classic Triad:** The diagnosis of pheochromocytoma is suggested by the triad of: 1. **Severe HEADACHE** (90% of patients) — often pounding, sudden-onset, occipital region; may be the worst headache of the patient's life. 2. **PALPITATIONS (60–90%)** — awareness of rapid or forceful heartbeat; often accompanied by tachycardia (HR >100 bpm), sometimes extreme (>150 bpm). 3. **PROFUSE DIAPHORESIS (60%)** — sudden, drenching sweating, often unrelated to ambient temperature; patient may soak clothing. These three symptoms are present in ~50% of pheochromocytoma patients and are highly suggestive of the diagnosis. If a patient presents with this triad, pheochromocytoma must be ruled out. **Other Classic Signs:** - **SEVERE HYPERTENSION:** Often markedly elevated (systolic >180 mmHg, diastolic >110 mmHg). The hypertension can be: - **Sustained:** High blood pressure throughout the day (from continuous catecholamine secretion). - **Paroxysmal (episodic):** Normal blood pressure with sudden attacks of severe hypertension lasting 15 minutes to 1 hour. Attacks can be triggered by physical activity (abdominal pressure), foods (tyramine-containing foods like aged cheese, cured meats, fermented foods), medications (stimulants, decongestants), or spontaneously. This pattern is pathognomonic (highly characteristic). - **Tremor:** Fine tremor from beta-adrenergic stimulation. - **Anxiety, fear, sense of impending doom:** Subjective feeling that "something terrible is about to happen." - **Pallor or flushing:** Pale skin alternating with facial flushing (from variable catecholamine-induced vasoconstriction/vasodilation). - **Chest or abdominal pain:** From hypertensive crisis or myocardial ischemia. - **Nausea, vomiting, weight loss:** From chronic catecholamine excess. **Paroxysmal Attacks ("Spell"):** If the tumor releases catecholamines episodically, the patient experiences: - **Sudden onset** (over seconds to minutes) of severe symptoms: pounding headache, palpitations, extreme anxiety, drenching sweat, tremor, and severe hypertension (systolic can reach 200–250 mmHg). - **Duration:** 15 minutes to several hours; then symptoms abruptly resolve. - **Frequency:** Attacks can occur daily, weekly, or monthly; sometimes predictable (e.g., always with exertion) or random. - **Triggers:** Abdominal pressure (bending, lifting, straining), full bladder, foods high in tyramine, sympathomimetic drugs (decongestants, stimulants), caffeine, exercise, or spontaneously. **Complications of Severe or Recurrent Hypertensive Crises:** - **Acute coronary syndrome (ACS):** Myocardial infarction from supply-demand mismatch (very high heart rate + high blood pressure + coronary vasoconstriction from catecholamines). - **Stroke:** From hypertensive surge causing intracerebral hemorrhage or thrombotic stroke. - **Hypertensive encephalopathy:** Severe headache, confusion, altered mental status, seizures from cerebral edema. - **Acute heart failure:** From acute increase in cardiac afterload and direct catecholamine cardiotoxicity ("catecholamine cardiomyopathy"). - **Arrhythmias:** Including ventricular fibrillation and sudden cardiac death. - **Aortic dissection:** From sustained high blood pressure. - **Acute kidney injury:** From hypertensive crisis damaging glomeruli. **Diagnosis:** **Step 1: Biochemical Confirmation** Biochemical testing is the cornerstone of diagnosis. Plasma catecholamines (epinephrine, norepinephrine) are elevated but can be normal between attacks, so 24-hour urine metanephrines and vanillylmandelic acid (VMA) are more reliable. - **24-Hour Urine Metanephrines (Most specific test):** Metanephrines are the metabolic breakdown products of catecholamines. A 24-hour urine metanephrine >400 mcg (normal <400) is virtually diagnostic of pheochromocytoma. - **Critical patient instruction:** For 3 days before collection, avoid: - Caffeine (coffee, tea, cola, chocolate). - Tyramine-rich foods (aged cheese, cured meats, fermented soy products, red wine). - Sympathomimetic drugs (decongestants, appetite suppressants, stimulants). - Certain medications (tricyclic antidepressants, venlafaxine, some antipsychotics, NSAIDs). - Failure to avoid these can cause false-positive results, so patient education is essential. - **24-Hour Urine Vanillylmandelic Acid (VMA):** Another catecholamine metabolite; sensitivity is lower than metanephrines but still useful. Same dietary restrictions apply. - **Plasma Free Catecholamines (Epinephrine + Norepinephrine):** Can be drawn; normal is <100 pg/mL each. However, stress can elevate catecholamines artificially, and baseline values between attacks may be normal, so 24-hour urine collection is preferred. - **Chromogranin A:** A general neuroendocrine marker; elevated in pheochromocytoma but not specific (also elevated in other neuroendocrine tumors and some medications). **Step 2: Anatomical Localization** Once biochemical confirmation is made, imaging is performed to locate the tumor and assess for metastases (malignancy): - **CT or MRI Abdomen/Pelvis:** First-line imaging; identifies the adrenal mass (usually 2–10 cm). Pheochromocytomas are highly vascular (bright enhancement with IV contrast) and often have a central area of lower density (necrosis/hemorrhage). - **Functional Imaging (131I-Metaiodobenzylguanidine [MIBG] Scintigraphy):** Specialized nuclear medicine scan using a radioactive tracer that is taken up by catecholamine-secreting cells. Detects both adrenal and extra-adrenal tumors and identifies metastases. Useful if the tumor is not found on CT/MRI or if there is suspicion of malignancy. - **PET-CT (Positron Emission Tomography):** Using tracers like 68Ga-DOTATATE or 11C-epinephrine; increasingly used for detecting metastases and extra-adrenal disease. - **MRI pituitary and hypothalamus:** If MEN2 or VHL is suspected, screen for concurrent endocrine tumors (medullary thyroid cancer, pituitary tumors). **Step 3: Genetic Testing (if familial form suspected)** - **RET, VHL, SDHA, SDHB, SDHC, SDHD, NF1 mutations:** Consider genetic testing if the patient is <40 years old, has bilateral tumors, extra-adrenal disease, or a family history of pheochromocytoma or hereditary syndromes. Genetic counseling is essential. **Management:** **Medical Management (Pre-operative Blood Pressure Control):** The most critical point: **NEVER give a beta-blocker alone or before an alpha-blocker.** Unopposed alpha-adrenergic stimulation from the tumor causes a life-threatening hypertensive crisis (hypertensive emergency with possibility of stroke, MI, or aortic dissection). **Correct Sequence:** 1. **Alpha-blockers FIRST (Days 1–7):** - **Phenoxybenzamine** (a non-selective, irreversible alpha-blocker): Starting dose 10 mg once or twice daily; increase every 2–3 days by 10 mg until blood pressure is controlled (target <160/100 mmHg) and symptoms improve. Typical effective dose is 40–80 mg daily in divided doses. Alternative: **doxazosin** (a selective alpha-1-blocker, more commonly used now) 1–2 mg daily, titrated to BP control. - **Goal:** Block the alpha-adrenergic effects of the tumor's catecholamines (peripheral vasoconstriction → hypertension). This prevents hypertensive crisis. - **Expected effects:** Blood pressure drops; patient may experience reflex tachycardia and symptoms of catecholamine release (palpitations, tremor) as alpha-blockade removes the vascular constriction, but this is expected and tolerated. - **Side effects:** Orthostatic hypotension (especially after the first dose), reflex tachycardia, nasal congestion. 2. **Beta-blockers SECOND (only after adequate alpha-blockade is achieved, around Day 7):** - **Propranolol** (non-selective beta-blocker): 40–80 mg daily in divided doses, titrated to heart rate and blood pressure. Alternatively, **esmolol** (short-acting IV beta-blocker) during perioperative period. - **Goal:** Control the reflex tachycardia and palpitations from alpha-blockade, and reduce the cardiac effects of catecholamines. - **CRITICAL:** Only give AFTER adequate alpha-blockade; beta-blocker alone without alpha-blockade allows unopposed alpha stimulation from the tumor, causing hypertensive crisis. - **Target heart rate:** 60–80 bpm. 3. **Calcium Channel Blockers (Alternative or Adjunctive):** - If the patient is intolerant of alpha-blockers or for additional blood pressure control: **diltiazem** or **nifedipine** can be used. These reduce blood pressure and provide some protection against cardiac ischemia. **Duration of Medical Management:** Typically 7–14 days before surgery to allow adequate alpha-blockade and volume expansion (catecholamine excess causes vasoconstriction and relative hypovolemia; alpha-blockade relaxes vessels and expands intravascular volume). **Surgical Removal (Adrenalectomy):** Once medical blood pressure control is achieved, **definitive treatment is surgical removal of the tumor (adrenalectomy).** **Pre-operative Preparation:** - Ensure adequate alpha- and beta-blockade (blood pressure <160/100 mmHg). - Check electrolytes, glucose, liver and kidney function. - EKG to assess for arrhythmias or ischemia from chronic catecholamine excess. - Ensure IV access; have vasodilators (phentolamine), vasopressors (phenylephrine), and beta-blockers (esmolol) available in the OR for intra-operative management. **Intra-operative Considerations:** - **Anesthetic agents:** Avoid drugs that trigger catecholamine release (e.g., atropine, ketamine). Use safe agents like etomidate or propofol for induction. - **DO NOT PALPATE the tumor** during abdominal exploration — physical manipulation of the tumor causes massive catecholamine release and life-threatening hypertensive crisis. The surgeon moves carefully to isolate the tumor and ligate its venous drainage first. - **Tumor vein ligation:** The venous drainage of the tumor is isolated and ligated before the tumor is mobilized; this prevents a final massive catecholamine release when the tumor is handled. - **Hemodynamic management:** Anesthesia closely monitors blood pressure and heart rate. If blood pressure spikes (hypertensive crisis during tumor manipulation), IV phentolamine (an alpha-blocker) is given; if tachycardia occurs, IV esmolol (beta-blocker) is given. Once the venous drainage is ligated, catecholamine levels drop dramatically and blood pressure falls—vasopressors (phenylephrine) may be needed. - **Peri-operative hydrocortisone:** Since an adrenal gland is being removed, peri-operative steroid coverage is given (as in pituitary/adrenal surgery). **Post-operative Nursing Care:** 1. **Monitor for Hemorrhage:** The adrenal gland is highly vascular. - Check vitals every 15–30 minutes; inspect dressing frequently. - Monitor Hemoglobin and Hematocrit; rising abdominal distention suggests internal bleeding. 2. **Monitor for Hypotension:** As catecholamine levels fall post-op, blood pressure drops (opposite of the hypertensive crisis during tumor handling). - Expect transient hypotension post-operatively (systolic 90–100 mmHg is not unusual). - **Support with IV fluids (normal saline).** The patient is often hypovolemic pre-operatively (chronic catecholamine-induced vasoconstriction reduced intravascular volume), so fluid replacement helps stabilize blood pressure. - If hypotension is severe (systolic <80 mmHg) or symptomatic, vasopressors (phenylephrine) may be needed briefly. 3. **Monitor Vital Signs, Blood Pressure, Heart Rate:** - Hypertensive episodes should resolve as catecholamine levels normalize. - Arrhythmias (from chronic catecholamine excess or intra-operative stress) may persist briefly; EKG monitoring is appropriate. 4. **Manage Pain:** Multimodal analgesia; pain is a stressor that increases catecholamine demand. 5. **Monitor Glucose:** If bilateral adrenalectomy is performed (rare for pheochromocytoma; usually only unilateral is removed), the patient loses all cortisol and requires lifelong steroid replacement. Monitor glucose and provide hydrocortisone as per adrenal insufficiency protocol. 6. **Infection Prevention:** Standard post-operative care; the patient is at normal infection risk (not immunosuppressed like in Cushing's syndrome). 7. **Early Mobilization and Recovery:** Encourage early ambulation to prevent DVT and promote healing. **Post-operative Follow-up:** - **Blood pressure normalization:** Most patients' hypertension resolves or dramatically improves after tumor removal. Some have residual hypertension (from months of catecholamine-induced vascular remodeling) that gradually improves over weeks to months. - **24-hour urine metanephrines:** Recheck at 1–2 weeks post-op to confirm normalization (indicates complete tumor removal). - **Imaging follow-up:** If malignancy is suspected, repeat CT/MRI and MIBG scan at 6 months and annually for 5 years to detect recurrence or metastases. - **Genetic testing and family screening:** If a hereditary syndrome is identified (MEN2, VHL, NF1, or familial paraganglioma), genetic counseling and screening of family members is indicated. Close relatives should be screened with 24-hour urine metanephrines. - **Antihypertensive tapering:** As blood pressure normalizes, reduce antihypertensive medications gradually. Many patients can discontinue medications post-operatively; others require ongoing therapy. **Long-term Outlook:** - **Cure rate:** ~90% of patients with benign, surgically resectable pheochromocytomas are cured. - **Recurrence:** <10% for benign tumors; higher for malignant tumors or familial syndromes. - **Quality of life:** After recovery, most patients report dramatic improvement in symptoms and quality of life.